These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2471696)

  • 1. CD1-positive epidermal Langerhans cells in skin reactions to autologous peripheral-blood-derived mononuclear cells in leprosy patients.
    Narayanan RB; Natarajan M; Katoch K; Sengupta U
    Int Arch Allergy Appl Immunol; 1989; 89(1):38-42. PubMed ID: 2471696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD1-positive epidermal Langerhans cells in regressed tuberculoid and lepromatous leprosy lesions.
    Narayanan RB; Girdhar A; Girdhar BK
    Int Arch Allergy Appl Immunol; 1990; 92(1):94-6. PubMed ID: 1700968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OKT6+ epidermal Langerhans' cell numbers in DNCB reactions among leprosy patients.
    Narayanan RB; Girdhar BK; Desikan KV
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):423-6. PubMed ID: 3755743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.
    Narayanan RB; Laal S; Sharma AK; Bhutani LK; Nath I
    Clin Exp Immunol; 1984 Mar; 55(3):623-8. PubMed ID: 6423326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lepromin-induced suppressor cells in lepromatous leprosy.
    Nelson EE; Wong L; Uyemura K; Rea TH; Modlin RL
    Cell Immunol; 1987 Jan; 104(1):99-104. PubMed ID: 2948676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum.
    Modlin RL; Mehra V; Jordan R; Bloom BR; Rea TH
    J Immunol; 1986 Feb; 136(3):883-6. PubMed ID: 2416837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of S-100 and OKT6 antisera in human skin.
    Modlin RL; Rowden G; Taylor CR; Rea TH
    J Invest Dermatol; 1984 Sep; 83(3):206-9. PubMed ID: 6381607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions.
    Shen JY; Hofman FM; Gunter JR; Modlin RL; Rea TH
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):494-8. PubMed ID: 2443587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ characterization of T lymphocyte subsets in the reactional states of leprosy.
    Modlin RL; Gebhard JF; Taylor CR; Rea TH
    Clin Exp Immunol; 1983 Jul; 53(1):17-24. PubMed ID: 6223731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal keratinocyte Ia expression, Langerhans cell hyperplasia and lymphocytic infiltration in skin lesions of leprosy.
    Rea TH; Shen JY; Modlin RL
    Clin Exp Immunol; 1986 Aug; 65(2):253-9. PubMed ID: 2431817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal changes in reactional leprosy: keratinocyte Ia expression as an indicator of cell-mediated immune responses.
    Thangaraj H; Laal S; Thangaraj I; Nath I
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):401-7. PubMed ID: 2458421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
    Job CK; Jacobson RR; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity in amyloidosis secondary to lepromatous leprosy.
    Anders EM; McAdam KP; Anders RF
    Clin Exp Immunol; 1977 Jan; 27(1):111-7. PubMed ID: 849644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerhans cells (CD1a and CD207), dermal dendrocytes (FXIIIa) and plasmacytoid dendritic cells (CD123) in skin lesions of leprosy patients.
    Hirai KE; Aarão TL; Silva LM; de Sousa JR; de Souza J; Dias LB; Carneiro FR; Fuzii HT; Quaresma JA
    Microb Pathog; 2016 Feb; 91():18-25. PubMed ID: 26639680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
    Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN
    Front Immunol; 2018; 9():189. PubMed ID: 29479352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The involvement of dendritic cells in the cutaneous lesions associated with tuberculoid and lepromatous leprosy.
    Collings LA; Waters MF; Poulter LW
    Clin Exp Immunol; 1985 Dec; 62(3):458-67. PubMed ID: 3910315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cell-mediated immune responses in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):36-41. PubMed ID: 3549939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions.
    Beuria MK; Mohanty KK; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):422-8. PubMed ID: 10700917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and extent of thickening of the nucleated epidermis in leprosy lesions.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):410-6. PubMed ID: 11332284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD1 positive epidermal Langerhans cells in indeterminate leprosy.
    Narayanan RB; Natarajan M; Katoch K; Bagga AK
    Acta Leprol; 1988; 6(1):29-34. PubMed ID: 3051852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.